Issue navigation
Volume 20, Issue 21, 1 November 1999
Does a sex bias really exist in the management of women with coronary heart disease?
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Page 1600, https://doi.org/10.1053/euhj.1999.1585
Trial design for heart failure studies
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1600–1601, https://doi.org/10.1053/euhj.1999.1648
Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1572–1578, https://doi.org/10.1053/euhj.1999.1662
Comparison of the predictive value of ST segment elevation resolution at 90 and 180min after start of streptokinase in acute myocardial infarction. A substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 Study
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1563–1571, https://doi.org/10.1053/euhj.1999.1664
Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1587–1591, https://doi.org/10.1053/euhj.1999.1696
Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1579–1586, https://doi.org/10.1053/euhj.1999.1712
Decrease in mortality in patients with a hospital diagnosis of atrial fibrillation in Denmark during the period 1980–1993
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1592–1599, https://doi.org/10.1053/euhj.1999.1713
Improving outcome in acute coronary syndromes — as good as it gets?
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1533–1537, https://doi.org/10.1053/euhj.1999.1765
Atrial fibrillation and mortality
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1525–1527, https://doi.org/10.1053/euhj.1999.1781
Depression and heart failure — not yet a target for therapy?
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1529–1531, https://doi.org/10.1053/euhj.1999.1821
Unstable angina: the breakthrough
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1517–1519, https://doi.org/10.1053/euhj.1999.1822
Plant lipids that lower serum cholesterol
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1527–1529, https://doi.org/10.1053/euhj.1999.1824
Different benefits, different risks, equal cost
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1531–1532, https://doi.org/10.1053/euhj.1999.1828
Specific antithrombins in the context of current treatment for acute coronary syndromes
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1519–1521, https://doi.org/10.1053/euhj.1999.1836
Evaluation of antiarrhythmic drug efficacy in patients with an ICD. Unlimited potential or replete with complexity and problems?
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1538–1552, https://doi.org/10.1053/euhj.1999.1850
Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome)
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1553–1562, https://doi.org/10.1053/euhj.1999.1879
ESC News and Appointments
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages I–IV, https://doi.org/10.1053/euhj.1999.1916
New trials of LMW heparins — light and heavy weight as good on short but what about longer distances?
European Heart Journal, Volume 20, Issue 21, 1 November 1999, Pages 1522–1524, https://doi.org/10.1053/euhj.1999.1918
